CITALOPRAM
- Manufacturer
- DIRECT RX
- Effective date
- 2016-04-12
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:22:11
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CITALOPRAM Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 475812f9-1b2c-4cb0-9e72-1e52f935ae6f | Product name | 1 | 20221114 |
| 0b05d650-9b7b-4b36-a6f4-1a850d5a2e64 | Product name | 1 | 20151228 |
| e61ea6cb-0b08-40a9-a984-7b23201c7aa2 | Product name | 1 | 20151222 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-288-30 | CITALOPRAM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-288-30 | EA - Each | 61919-288 | 54477e8d-d1d5-485b-97a8-e7c63514f1f1 | 1 | 2016-09-02 |
| 65162-052-03 | EA - Each | 65162-052 | ce515dd7-9f90-4ef1-bb93-132d3693c4c7 | 1 | 2013-02-13 |
| 65162-052-10 | EA - Each | 65162-052 | 201ee70a-34a2-4ad6-b931-d60463d51e5e | 1 | 2012-07-24 |
| 65162-052-50 | EA - Each | 65162-052 | ea71cf45-b903-4ac2-9542-5a4f04a0b2b0 | 1 | 2012-07-24 |
Products#
Every source-derived product name is available through these pages.
- CITALOPRAM
- GLYCERIN
- LACTOSE MONOHYDRATE
- POLYVINYL ALCOHOL
- TITANIUM DIOXIDE
- FERRIC OXIDE YELLOW
- FERRIC OXIDE RED
- CELLULOSE, MICROCRYSTALLINE
- STARCH, CORN
- MAGNESIUM STEARATE
- POLYETHYLENE GLYCOLS
- SODIUM STARCH GLYCOLATE TYPE A POTATO
- TALC
- CITALOPRAM HYDROBROMIDE
- POVIDONE K12
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61919-288 | 61919-288-30 |
| 65162-052 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077289-001 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | 2006-11-30 | ||
| A077289-002 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2006-11-30 | ||
| A077289-003 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2006-11-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | 2006-11-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2006-11-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2006-11-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | 2006-11-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2006-11-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2006-11-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077289-002 | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | AB | 2006-11-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077289-003 | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | AB | 2006-11-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077289-001 | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2006-11-30 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A077289-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077289-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077289-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077289-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077289-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077289-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A077289-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077289-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077289-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077289-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077289-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077289-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077289-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077289-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077289-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077289-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077289-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077289-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077289-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077289-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077289-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077289-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077289-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077289-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077289-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077289-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077289-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A077289-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A077289-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A077289-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077289-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077289-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077289-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077289-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077289-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077289-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077289-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077289-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077289-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A077289-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Citalopram | CITALOPRAM | Amneal Pharmaceuticals LLC | 6a402640-1c9d-4fca-8b5b-e1ac1dd4ca5a | 2024-09-23 | Boxed warning, Warnings, Adverse reactions | 65162-052 |
| 304f1d5a-2190-51ae-e054-00144ff88e88 | 304f1d5a-218f-51ae-e054-00144ff88e88 | 2016-04-12 | Warnings, Adverse reactions | 304f1d5a-2190-51ae-e054-00144ff88e88 304f1d5a-218f-51ae-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
